This website requires JavaScript.
RES Capital

Value

Our Fund investments deliver "Value Drivers" to Investee companies for their ‘Up-Rising’, through our Fund Manager’s active participation in operations, expansion initiatives and strategic development activities.

Value creation for our Investee Up-Rising (Ep-Anodos) is performed through detailed monitoring and interventions of the following:

  • Balance Sheet Restructuring
  • Management Enhancement
  • New Market Penetration
  • Organic Growth
  • External Growth (i.e. M&A)
  • New Product Development
  • New Internal Process Development

Our Fund Manager assumes an active role in promoting the restructuring, reorganization and development of investee companies to foster the modernization of business practices and improve working capital utilization.

About us

RESCAPITAL S.A. manages newly formed RESFUND VCMF, a €30M closed-end venture capital fund with a 10-year duration, in line with the provisions of Law 2992/2002 and HDBI’s ‘EP-ANODOS’ Fund Framework.

RESFUND VCMF invests in SMEs, maintaining an establishment in the Greek territory at the time of the investment, which need restructuring/reorganization for rebound/turnaround/growth and engage primarily in manufacturing and processing operations.

Portfolio

Our current investment portfolio includes the following investee companies

Cententia
Pharmamax
Principles

Principles

We aim at producing superior risk-adjusted returns for its investments by:

  • Ensuring a path for return of capital that is independent of future capital market conditions.
  • Preferring to work directly with existing shareholders to maximize value creation.
  • Focusing on enterprise growth, enhancement of operations and financial deleveraging.
  • Actively participating in operational efficiencies, expansion initiatives and strategic development activities.
Learn more